Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study

INTRODUCTION: Injectable therapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and basal insulin (BI) are well-established agents for people with type 2 diabetes (T2D). This study aimed to investigate real-world effectiveness of GLP-1 RAs or BI in adults with T2D poorly controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xuejun Victor, McCrimmon, Rory J., Shepherd, Leah, Boss, Anders, Lubwama, Robert, Dex, Terry, Skolnik, Neil, Ji, Linong, Avogaro, Angelo, Blonde, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547934/
https://www.ncbi.nlm.nih.gov/pubmed/32902774
http://dx.doi.org/10.1007/s13300-020-00905-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547934/
https://www.ncbi.nlm.nih.gov/pubmed/32902774
http://dx.doi.org/10.1007/s13300-020-00905-y

Ejemplares similares